MALVERN, PA — Neuronetics, Inc. (Nasdaq: STIM) has partnered with ANT Neuro to integrate image-guided neuronavigation technology into its NeuroStar transcranial magnetic stimulation platform, as providers increasingly seek more personalized and standardized treatment workflows for neurohealth disorders.
The partnership will pair ANT Neuro’s FDA-cleared visor2 neuronavigation system with NeuroStar Advanced Therapy systems, allowing clinicians to use real-time spatial tracking and 3D visualization during treatment delivery.
Neuronetics indicated the collaboration is intended to expand treatment visualization and improve consistency in coil positioning during TMS procedures, which are commonly used to treat conditions including major depressive disorder.
“By combining NeuroStar’s established TMS platform with ANT Neuro’s neuronavigation technology, we are continuing to invest in innovations aligned with the evolving needs of TMS providers,” Chief Executive Officer Dan Reuvers stated.
The company’s NeuroStar platform already includes patented contact sensing technology designed to support consistent treatment delivery. The addition of neuronavigation capabilities could further support providers seeking more individualized targeting approaches during therapy sessions.
Providers across the TMS market have increasingly explored technologies focused on workflow integration, visualization and treatment standardization as adoption of noninvasive neurostimulation therapies expands.
ANT Neuro Chief Executive Officer KC Chelette described the agreement as an effort to bring advanced neuronavigation tools to a broader TMS provider base.
“Together, we aim to provide clinicians with tools that support visualization, consistency, and confidence throughout the treatment process,” Chelette stated.
Neuronetics reported that NeuroStar has the largest installed base of TMS systems in the United States, positioning the company to scale additional workflow and treatment-delivery technologies across existing provider networks.
A broader commercial rollout of the integrated technology is planned for the second half of 2026.
Support the local news that supports Chester County. MyChesCo delivers reliable, fact-based reporting and essential community resources—free for everyone. If you value that, click here to become a patron today.